Suzuken Co., Ltd. (SZUKF) Research

Suzuken Co., Ltd., along with its affiliated companies, operates primarily as a global wholesaler of pharmaceutical products, with a strong presence both in Japan and internationally. The company's diverse activities are structured into four main divisions: Pharmaceutical Distribution, Pharmaceutical Manufacturing, Pharmacy Services, and Healthcare-Related Services. The Pharmaceutical Distribution segment focuses on sourcing a wide array of items, including prescription medications, diagnostic substances, various medical devices and supplies, and other health-focused goods directly from manufacturers. These products are then supplied to medical facilities and pharmacies. In its Pharmaceutical Manufacturing division, Suzuken engages in the research, development, production, and marketing of ethical pharmaceuticals and diagnostic tools, with a particular emphasis on treatments for diabetes and kidney diseases. Through its Pharmacy Services segment, the company provides support via community pharmacists, while also striving to optimize the operations of local pharmacies and offering essential educational assistance. Finally, the Healthcare-Related Services division offers a broad spectrum of functions. This includes providing support for manufacturers, such as outsourced distribution and the specialized distribution of orphan drugs, in addition to delivering nursing care services. This segment is also responsible for the design, manufacturing, and sale of medical instruments like ECG machines, blood pressure monitors, and stethoscopes, as well as general medical materials and equipment for health promotion. Beyond these core business areas, Suzuken Co., Ltd. also publishes medical periodicals specifically for healthcare professionals and institutions. The company has also forged a strategic alliance with Bushu Pharmaceuticals Ltd. to offer specialized contract drug services. Suzuken Co., Ltd. was established in 1932 and is headquartered in Nagoya, Japan.

Open Suzuken Co., Ltd. (SZUKF) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.